NCT06394622View on ClinicalTrials.gov

A Clinical Research About CD70-targeted CAR-NKT Cells Therapy Advanced Malignant Solid Tumors

PHASE1RecruitingINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

April 11, 2024

Primary Completion Date

June 28, 2026

Study Completion Date

June 28, 2026

Conditions
Solid Tumor
Interventions
COMBINATION_PRODUCT

Cyclophosphamide + Fludarabine + Infusion of CAR-NKT Cells

Biological: CD70 CAR-NKT cells. Drug: Cyclophosphamide. Drug: Fludarabine.

Trial Locations (1)

Unknown

RECRUITING

Fudan University, Shanghai

All Listed Sponsors
lead

Fudan University

OTHER